SomnoMed Future Growth
Future criteria checks 1/6
SomnoMed is forecast to grow revenue at 9.7% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Medical Equipment earnings growth | 16.7% |
Revenue growth rate | 9.7% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 25 Apr 2024 |
Recent future growth updates
Recent updates
SomnoMed Limited (ASX:SOM) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Apr 15SomnoMed (ASX:SOM) Has Debt But No Earnings; Should You Worry?
Mar 04Market Still Lacking Some Conviction On SomnoMed Limited (ASX:SOM)
Dec 21SomnoMed Limited (ASX:SOM) Could Be Riskier Than It Looks
Sep 02Is SomnoMed (ASX:SOM) Using Too Much Debt?
Jun 19It's Unlikely That SomnoMed Limited's (ASX:SOM) CEO Will See A Huge Pay Rise This Year
Nov 18SomnoMed (ASX:SOM) Has Debt But No Earnings; Should You Worry?
Sep 27Is SomnoMed (ASX:SOM) Using Debt Sensibly?
May 10Is SomnoMed (ASX:SOM) Using Debt Sensibly?
Oct 26Health Check: How Prudently Does SomnoMed (ASX:SOM) Use Debt?
May 12Could The SomnoMed Limited (ASX:SOM) Ownership Structure Tell Us Something Useful?
Mar 02Have Insiders Been Buying SomnoMed Limited (ASX:SOM) Shares?
Feb 01Is SomnoMed (ASX:SOM) Using Debt In A Risky Way?
Dec 28Is SomnoMed Limited (ASX:SOM) Trading At A 38% Discount?
Dec 01Analysts Just Published A Bright New Outlook For SomnoMed Limited's (ASX:SOM)
Jul 28SomnoMed Limited (ASX:SOM) Insiders Increased Their Holdings
Jul 14Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2026 | 113 | N/A | N/A | N/A | 1 |
6/30/2025 | 103 | N/A | N/A | N/A | 1 |
6/30/2024 | 93 | N/A | N/A | N/A | 1 |
12/31/2023 | 89 | -11 | -10 | -5 | N/A |
9/30/2023 | 86 | -9 | -10 | -4 | N/A |
6/30/2023 | 84 | -8 | -10 | -4 | N/A |
3/31/2023 | 81 | -7 | -11 | -3 | N/A |
12/31/2022 | 79 | -5 | -11 | -2 | N/A |
9/30/2022 | 76 | -5 | -9 | 0 | N/A |
6/30/2022 | 73 | -4 | -7 | 2 | N/A |
3/31/2022 | 69 | -5 | -6 | 1 | N/A |
12/31/2021 | 66 | -5 | -6 | -1 | N/A |
9/30/2021 | 64 | -3 | -4 | 1 | N/A |
6/30/2021 | 63 | -1 | -1 | 3 | N/A |
3/31/2021 | 59 | -1 | 2 | 5 | N/A |
12/31/2020 | 55 | -1 | 5 | 7 | N/A |
9/30/2020 | 56 | -1 | 4 | 6 | N/A |
6/30/2020 | 57 | 0 | 3 | 5 | N/A |
3/31/2020 | 60 | 0 | 0 | 2 | N/A |
12/31/2019 | 63 | 1 | -4 | -1 | N/A |
9/30/2019 | 61 | 0 | -6 | -4 | N/A |
6/30/2019 | 59 | 0 | -8 | -7 | N/A |
3/31/2019 | 58 | 2 | N/A | N/A | N/A |
12/31/2018 | 56 | 3 | -9 | -7 | N/A |
9/30/2018 | 54 | 3 | -10 | -8 | N/A |
6/30/2018 | 52 | 2 | -12 | -9 | N/A |
3/31/2018 | 51 | -1 | N/A | N/A | N/A |
12/31/2017 | 50 | -4 | -11 | -8 | N/A |
9/30/2017 | 50 | -4 | N/A | -5 | N/A |
6/30/2017 | 49 | -3 | N/A | -3 | N/A |
3/31/2017 | 48 | -2 | N/A | -1 | N/A |
12/31/2016 | 47 | -1 | N/A | 0 | N/A |
9/30/2016 | 45 | 0 | N/A | 1 | N/A |
6/30/2016 | 44 | 0 | N/A | 2 | N/A |
3/31/2016 | 42 | 0 | N/A | 2 | N/A |
12/31/2015 | 39 | 1 | N/A | 1 | N/A |
9/30/2015 | 37 | 1 | N/A | 0 | N/A |
6/30/2015 | 34 | 1 | N/A | 0 | N/A |
3/31/2015 | 34 | 1 | N/A | 0 | N/A |
12/31/2014 | 35 | 1 | N/A | -1 | N/A |
9/30/2014 | 32 | 1 | N/A | -1 | N/A |
6/30/2014 | 30 | 0 | N/A | -1 | N/A |
3/31/2014 | 26 | 0 | N/A | 0 | N/A |
12/31/2013 | 22 | 0 | N/A | 0 | N/A |
9/30/2013 | 20 | 0 | N/A | 0 | N/A |
6/30/2013 | 18 | 1 | N/A | 1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if SOM's forecast earnings growth is above the savings rate (2.2%).
Earnings vs Market: Insufficient data to determine if SOM's earnings are forecast to grow faster than the Australian market
High Growth Earnings: Insufficient data to determine if SOM's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: SOM's revenue (9.7% per year) is forecast to grow faster than the Australian market (4.7% per year).
High Growth Revenue: SOM's revenue (9.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SOM's Return on Equity is forecast to be high in 3 years time